We work to improve the life quality of people in Turkey and the world with our strong R&D organization, our state-of-the-art and value-added wide product portfolio covering all the major fields of treatment, our operations in the fields of biotechnology and consumer health based on our more than 50 years of knowledge and experience.
We have
						a wide product portfolio covering all the major treatment areas including cardiology, central
						nervous system, rare diseases and acute products.
We created Wellcare brand in
						2016 to generate right solutions to the new emerged needs and bring a new breath to the consumer
						health field within the framework of our approach to handle consumer health as a whole. Wellcare
						aims to offer solutions to health problems and raise the quality of life at every stage of life
						as of birth with its innovative, clinically-proven, scientific and reliable after-care treatment
						products that are approved by health authorities in 5 different categories: Digestive Health,
						Probiotics, Allergy, Vitamins and Minerals, Cold and Cough.
As ILKO, we had partnered with South Korean
						Genexine and founded Ilkogen, the first biotechnology pharmaceutical R&D, production and
						international marketing company of Turkey. Following Ilkogen that commenced operations in 2013,
						we had established our Biotechnology R&D Center in 2015. At this center, we primarily work
						on developing biotechnology products for cancer and cancer-related diseases. We are still
						working on biosuperior, nano-biosuperior, biosimilar and next generation biotechnology products.
					We carry out our R&D operations at two different centers.
 We develop state-of-the-art and
								value-added products at ILKO ARGEM (Ilko Research and Development Center) that commenced
								operations in 2009.
 We research and develop biotechnology
								products at ILKO Biotechnology R&D Center that was founded within Istanbul
								Technopark in 2015.As ILKO, we enter into strategic partnerships for our production operations. The capacity of these long-term partnerships with national and international companies including Servier, a leading pharmaceutical company of the world, increases every year.


We purpose to multiply the stories of happy people in over 35 countries.
As İlko Pharmaceuticals, we have export activities in over 35 countries and licensing activities in over 40 countries.
50+ years experience
184 products, 90 diffrent molecules
25.000 m2 manufacturing area on 250.000 m2 land
2.600 m2 high potent production area (İlkopol)
1.000+ employees
Export to 35+ countries
Strong oncologic drugs pipeline
R&D and Biotechnology Centers